First Trust Advisors’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
Other funds holding EDIT
CS
NAMA
First Trust Advisors's EDIT Position: Q1 2022 in Review
First Trust Advisors sold out of Editas Medicine (EDIT) in Q1 2022, closing a stake of 26,456 shares — an estimated $702K sold.
First Trust Advisors first reported a position in EDIT in Q2 2018 and held it in 13 quarters. The position peaked at $3.9M in Q3 2018. 256 funds tracked by Wall St. Rank hold EDIT as of Q1 2022.
- First Trust Advisors reported no remaining Editas Medicine position as of Q1 2022 after selling out during the quarter.
- First Trust Advisors sold 26,456 Editas Medicine shares in Q1 2022, an estimated $702K.
- First Trust Advisors first reported a position in Editas Medicine in Q2 2018 and held it in 13 quarters.
- First Trust Advisors's Editas Medicine position peaked at $3.9M in Q3 2018.
- 256 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2022.
Based on First Trust Advisors's 13F filing for Q1 2022, filed 13 May 2022.